Marina Pourafkari
Overview
Explore the profile of Marina Pourafkari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pourafkari M, Connelly K, Verma S, Mazer C, Teoh H, Quan A, et al.
Cardiovasc Diabetol
. 2024 Aug;
23(1):319.
PMID: 39198860
Background: Sodium-glucose cotransporter-2 (SGLT2) inhibitors have demonstrated reduction in heart failure outcomes in patients with type 2 diabetes mellitus, although the exact mechanism of benefit remains unclear. Alteration in left...
2.
Wilken B, Moran-Mendoza O, Pourafkari M, Asai Y
JAAD Case Rep
. 2024 Jul;
50:12-15.
PMID: 39036621
No abstract available.
3.
Neder J, Santyr G, Zanette B, Kirby M, Pourafkari M, James M, et al.
COPD
. 2024 Feb;
21(1):2301549.
PMID: 38348843
Exertional dyspnea, a key complaint of patients with chronic obstructive pulmonary disease (COPD), ultimately reflects an increased inspiratory neural drive to breathe. In non-hypoxemic patients with largely preserved lung mechanics...
4.
Rogalla P, OBrien C, Pakkal M, Kandel S, Sarie N, Cusimano R, et al.
Can Assoc Radiol J
. 2023 Aug;
75(1):191-195.
PMID: 37530532
No abstract available.
5.
Lee P, Dhillon G, Pourafkari M, Dabreo D, Jaff Z, Appireddy R, et al.
Int J Stroke
. 2023 Jul;
19(2):189-198.
PMID: 37515467
Background: A significant portion of cryptogenic stroke is hypothesized to be secondary to cardiac embolism. However, transthoracic echocardiogram is usually delayed after stroke, and more detailed cardiac imaging is not...
6.
Iliuta I, Win A, Lanktree M, Lee S, Pourafkari M, Nasri F, et al.
Sci Rep
. 2023 Feb;
13(1):2952.
PMID: 36807559
Using age- and height-adjusted total kidney volume, the Mayo Clinic Imaging Classification provides a validated approach to assess the risk of chronic kidney disease (CKD) progression in autosomal dominant polycystic...
7.
Pourafkari M, Pal P, Luk A, Ennis D, Pakkal M, Rogalla P
Br J Cardiol
. 2022 Jun;
27(3):28.
PMID: 35747772
(IgG4-RD) is a systemic fibro-inflammatory immune-mediated disease, which has been defined in the past few years. IgG4-RD affects various organs and leads to a variety of clinical manifestations. As it...
8.
Neder J, Kirby M, Santyr G, Pourafkari M, Smyth R, Phillips D, et al.
Chest
. 2022 Apr;
162(5):1030-1047.
PMID: 35390329
In people with COPD, pulmonary gas-exchange efficiency may be impaired because of abnormal alveolar ventilation (V˙A), capillary perfusion (Q˙c), or both. Both have been reported in early and mild stages...
9.
Rai A, Connelly K, Verma S, Mazer C, Teoh H, Ng M, et al.
Acta Diabetol
. 2022 Jan;
59(4):575-578.
PMID: 35061101
No abstract available.
10.
Lanktree M, Guiard E, Akbari P, Pourafkari M, Iliuta I, Ahmed S, et al.
Clin J Am Soc Nephrol
. 2021 Feb;
16(3):374-383.
PMID: 33602752
Background And Objectives: Progression of autosomal dominant polycystic kidney disease (ADPKD) is highly variable. On average, protein-truncating mutations are associated with the most severe kidney disease among all mutation classes....